30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Structure Therapeutics Inc (GPCR)

Track

The most recent insider trading activity at Structure Therapeutics Inc. occurred on June 10, 2024. A significant proposed sale of 185,000 shares valued at $9,767,352.50 was reported by Officer RAYMOND C STEVENS. Another proposed sale by Officer XICHEN LIN on June 3, 2024, involved 59,000 shares worth $2,017,800.00.
Stock chart
Ticker: GPCR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RAYMOND C STEVENS
Officer
1 sale — total 9,767,353 USD
Proposed sale 10 Jun 2024
Value US$3,966,784.49 | Price 244.71 | Shares 95,665
Proposed sale 3 Jun 2024
Value US$2,233,989.23 | Price 79.60 | Shares 62,604
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-10 2024-06-10 PrS Proposed sale
3.0
RAYMOND C STEVENS

Officer

Officer
95,665
244.71
US$3,966,784 		95,665 244.71 US$3,966,784
2024-06-03 2024-06-03 PrS Proposed sale
XICHEN LIN

Officer

Officer
62,604
79.60
US$2,233,989 		62,604 79.60 US$2,233,989
Explore more

More insider trading research around Structure Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America